|

Improving Adherence to Chronic Disease Medication Regimens Among Patients With Recently Diagnosed Cancer

RECRUITINGN/ASponsored by Duke University
Actively Recruiting
PhaseN/A
SponsorDuke University
Started2026-11-30
Est. completion2027-06-30
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site

Summary

This pilot study evaluates a pharmacist-led medication adherence intervention and Medisafe mobile application among patients with newly diagnosed cancer and multimorbidity. Thirty participants will be randomized to intervention or usual care to assess feasibility, acceptability, usability, and preliminary efficacy.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* diagnosed with breast, colorectal, lung or prostate cancer in the previous 12 months
* had no prior diagnosis of cancer
* are currently undergoing chemotherapy or radiation and/or underwent surgery in the prior 3 months
* had \>2 chronic conditions for \>1 year prior to cancer diagnosis
* are prescribed \>1 non-cancer medication(s)

Exclusion Criteria:

* cannot read and communicate in English
* do not have a smartphone

Conditions1

Cancer

Locations1 site

Duke University
Durham, North Carolina, 27710
Jhoanna Aquino9196606189jhoannazaida.aquino@duke.edu

Find trials near these locations

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.